Starbucks Corporation (SBUX) Q4 2022 Earnings Call Transcript

Nov. 03, 2022 10:16 PM ETStarbucks Corporation (SBUX)
SA Transcripts profile picture
SA Transcripts
133.67K Followers

Starbucks Corporation (NASDAQ:SBUX) Q4 2022 Earnings Conference Call November 3, 2022 5:00 PM ET

Company Participants

Tiffany Willis - VP of IR

Howard Schultz - Interim-CEO

Frank Britt - EVP, Chief Strategy and Transformation Officer

Sara Trilling - EVP and President, Starbucks North America

Rachel Ruggeri - EVP and CFO

Michael Conway - Group President, International and Channel Development

Belinda Wong - Chairwoman, Starbucks China

Conference Call Participants

Andrew Charles - Cowen

Jeffrey Bernstein - Barclays

Sara Senatore - Bank of America

Lauren Silberman - Credit Suisse

John Ivankoe - JPMorgan

Jon Tower - Citi

John Glass - Morgan Stanley

David Tarantino - Baird

Nicole Miller - Piper Sandler

Danilo Gargiulo - Bernstein

Operator

Good afternoon. My name is Diego, and I will be your conference operator today. I would like to welcome everyone to Starbucks' Fourth Quarter and Fiscal Year End 2022 Conference Call. [Operator Instructions]

I would now turn the call over to Tiffany Willis, Vice President of Investor Relations. Ms. Willis, you may now begin your conference.

Tiffany Willis

Thank you, Diego, and good afternoon, everyone. And thank you for joining us today to discuss Starbucks' fourth quarter and fiscal year 2022 results. Today's discussion will be led by Howard Schultz, Interim Chief Executive Officer; Frank Britt, Executive Vice President, Chief Strategy and Transformation Officer; Sara Trilling, Executive Vice President and President of Starbucks North America; and Rachel Ruggeri, Executive Vice President and CFO. And for Q&A, we will be joined by Laxman Narasimhan, Incoming Chief Executive Officer; Michael Conway, Group President of International and Channel Development; and Belinda Wong, Chairwoman of Starbucks China.

This conference call will include forward-looking statements, which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements. Any such statements should be considered in conjunction

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.